ArticleVeterinary research2026
RNF187 inhibits porcine reproductive and respiratory syndrome virus replication by recruiting the autophagy receptor NDP52 to degrade nsp12.
Article in Veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Porcine reproductive and respiratory syndrome is one of the most devastating diseases affecting global swine production. Viral nonstructural protein 12 (nsp12) is a key factor in viral replication during viral subgenomic RNA synthesis. We identified the host E3 ubiquitin ligase RING finger protein 187 (RNF187) as a novel anti-porcine reproductive and respiratory syndrome virus (PRRSV) host-restriction factor. RNF187 directly interacts with nsp12, and the overexpression of RNF187 significantly inhibits the expression of the viral nucleocapsid (N) protein and the titer of viruses, whereas the knockdown of RNF187 promotes viral replication. Mechanistic studies showed that RNF187 mediates the degradation of nsp12 in a dose-dependent manner. This degradation process can be blocked by the autophagy inhibitor, 3-methyladenine (3-MA). These results indicate that RNF187 degrades nsp12 via the autophagy pathway rather than the proteasome pathway. Mechanistically, RNF187 acts as a scaffold protein to recruit the autophagic cargo receptor NDP52 and promotes the K63-linked polyubiquitination at lysine 130 (K130) of nsp12, thereby targeting nsp12 for autophagy-lysosomal degradation. This study revealed a novel host defense mechanism mediated by the RNF187-NDP52 axis, which restricts PRRSV infection by targeting nsp12, thereby providing a potential target for the development of antiviral strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.